Lasa Supergenerics Limited (NSE:LASA)
India · Delayed Price · Currency is INR 4.220
0.00 (0.00%)
Nov 9, 2026, 3:18 PM IST
Lasa Supergenerics Market Cap
Lasa Supergenerics has a market cap or net worth of 211.43 million as of November 10, 2026. It is the 47,597th most valuable company in the world and the 4,702nd biggest in India. Its market cap has decreased by 62.62% in one year.
Market Cap
211.43M
Enterprise Value
301.93M
Revenue
65.20M
Global Rank
Country Rank
#4,702 India
PE Ratio
n/a
ChartMarket Cap Chart
Since September 22, 2017, Lasa Supergenerics's market cap has decreased from 3.53B to 211.43M, a decrease of -94.02%. That is a compound annual growth rate of -26.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 211.43M | -55.30% |
| Dec 31, 2025 | 472.96M | -62.89% |
| Dec 31, 2024 | 1.27B | -14.92% |
| Dec 29, 2023 | 1.50B | 9.45% |
| Dec 30, 2022 | 1.37B | -50.95% |
| Dec 31, 2021 | 2.79B | -18.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bafna Pharmaceuticals | 10.75B |
| Sigachi Industries | 10.53B |
| Amanta Healthcare | 7.58B |
| Valiant Laboratories | 6.31B |
| Nectar Lifesciences | 1.97B |
| Brooks Laboratories | 1.86B |
| Par Drugs and Chemicals | 1.34B |
| Balaxi Pharmaceuticals | 1.21B |